186 related articles for article (PubMed ID: 38475733)
1. The micro-743a-3p-GSTM1 pathway is an endogenous protective mechanism against alcohol-related liver disease in mice.
Xu T; Pan Y; Ding Q; Cao F; Chang K; Qiu J; Zhuge H; Hao L; Wei H; Si C; Dou X; Li S
Cell Mol Biol Lett; 2024 Mar; 29(1):35. PubMed ID: 38475733
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.
Lan T; Hu Y; Hu F; Li H; Chen Y; Zhang J; Yu Y; Jiang S; Weng Q; Tian S; Ma T; Yang G; Luo D; Wang L; Li K; Piao S; Rong X; Guo J
J Hepatol; 2022 Feb; 76(2):407-419. PubMed ID: 34656650
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific deletion of cellular repressor of E1A-stimulated genes 1 exacerbates alcohol-induced liver injury by activating stress kinases.
Wu M; Yin F; Wei X; Ren R; Chen C; Liu M; Wang R; Yang L; Xie R; Jiang S; Wang Z; Liu R; Xu W; Wang X; Li J; Wang H
Int J Biol Sci; 2022; 18(4):1612-1626. PubMed ID: 35280676
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin-1 signaling.
Chen X; Bian M; Jin H; Lian N; Shao J; Zhang F; Zheng S
IUBMB Life; 2019 Nov; 71(11):1740-1750. PubMed ID: 31265202
[TBL] [Abstract][Full Text] [Related]
5. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development.
Song Q; Chen Y; Wang J; Hao L; Huang C; Griffiths A; Sun Z; Zhou Z; Song Z
J Hepatol; 2020 Oct; 73(4):783-793. PubMed ID: 32389809
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
Toxicol Sci; 2017 Feb; 155(2):432-443. PubMed ID: 27837167
[TBL] [Abstract][Full Text] [Related]
7. Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor.
Wang Z; Miu KK; Zhang X; Wan AT; Lu G; Cheung HH; Lee HM; Kong AP; Chan JC; Chan WY
JHEP Rep; 2020 Dec; 2(6):100179. PubMed ID: 33134908
[TBL] [Abstract][Full Text] [Related]
8. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
9. Oxidative and ER stress-dependent ASK1 activation in steatotic hepatocytes and Kupffer cells sensitizes mice fatty liver to ischemia/reperfusion injury.
Imarisio C; Alchera E; Bangalore Revanna C; Valente G; Follenzi A; Trisolini E; Boldorini R; Carini R
Free Radic Biol Med; 2017 Nov; 112():141-148. PubMed ID: 28739531
[TBL] [Abstract][Full Text] [Related]
10. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
[TBL] [Abstract][Full Text] [Related]
11. Ischemia/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation.
Alchera E; Chandrashekar BR; Clemente N; Borroni E; Boldorini R; Carini R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831394
[TBL] [Abstract][Full Text] [Related]
12. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
13. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
14. Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1/p38MAPKα-dependent mechanisms.
Ma J; Cao H; Rodrigues RM; Xu M; Ren T; He Y; Hwang S; Feng D; Ren R; Yang P; Liangpunsakul S; Sun J; Gao B
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544093
[TBL] [Abstract][Full Text] [Related]
15. DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.
Xie L; Wang PX; Zhang P; Zhang XJ; Zhao GN; Wang A; Guo J; Zhu X; Zhang Q; Li H
J Hepatol; 2016 Jul; 65(1):113-124. PubMed ID: 27016281
[TBL] [Abstract][Full Text] [Related]
16. Phosphoproteomics identifies pathways underlying the role of receptor-interaction protein kinase 3 in alcohol-associated liver disease and uncovers apoptosis signal-regulating kinase 1 as a target.
Singh V; Huang E; Pathak V; Willard BB; Allende DS; Nagy LE
Hepatol Commun; 2022 Aug; 6(8):2022-2041. PubMed ID: 35438255
[TBL] [Abstract][Full Text] [Related]
17. Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway.
Xu L; Zhang X; Xin Y; Ma J; Yang C; Zhang X; Hou G; Dong XC; Sun Z; Xiong X; Cao X
Cell Death Dis; 2021 Jul; 12(7):710. PubMed ID: 34267188
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression.
Jin Y; Tan Y; Zhao P; Guo Y; Chen S; Wu J; Ren Z
Commun Biol; 2022 Apr; 5(1):326. PubMed ID: 35388144
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice.
Yu Y; Tian T; Tan S; Wu P; Guo Y; Li M; Huang M
Bioengineered; 2022 Feb; 13(2):2927-2942. PubMed ID: 35038955
[TBL] [Abstract][Full Text] [Related]
20. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Xiang M; Wang PX; Wang AB; Zhang XJ; Zhang Y; Zhang P; Mei FH; Chen MH; Li H
J Hepatol; 2016 Jun; 64(6):1365-77. PubMed ID: 26860405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
